What is Vaidyane Ayurved Laboratories Enterprise Value?
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Vaidyane Ayurved Laboratories Enterprise Value Chart
Competitive Comparison of Vaidyane Ayurved Laboratories's Enterprise Value
For the Drug Manufacturers - Specialty & Generic subindustry, Vaidyane Ayurved Laboratories's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vaidyane Ayurved Laboratories's Enterprise Value Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Vaidyane Ayurved Laboratories's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Vaidyane Ayurved Laboratories's Enterprise Value falls into.
Vaidyane Ayurved Laboratories Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Vaidyane Ayurved Laboratories's EV-to-EBIT for today is
Vaidyane Ayurved Laboratories's current Enterprise Value is ₹1,340.8 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Vaidyane Ayurved Laboratories's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ₹31.1 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Vaidyane Ayurved Laboratories's EV-to-EBITDA for today is:
Vaidyane Ayurved Laboratories's current Enterprise Value is ₹1,340.8 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Vaidyane Ayurved Laboratories's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ₹62.5 Mil.
Vaidyane Ayurved Laboratories's current Enterprise Value is ₹1,340.8 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Vaidyane Ayurved Laboratories's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ₹993.3 Mil.
Vaidyane Ayurved Laboratories's current Enterprise Value is ₹1,340.8 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Vaidyane Ayurved Laboratories's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was ₹-155.5 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vaidyane Ayurved Laboratories Enterprise Value Related Terms
Thank you for viewing the detailed overview of Vaidyane Ayurved Laboratories's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Vaidyane Ayurved Laboratories Business Description
Vaidya Sane Ayurved Laboratories Ltd is a medical service institution engaged in the treatment of chronic ailments like cardiac disease, diabetes, hypertension, and obesity by combining modern technology with traditional Ayurveda practices. It uses non-invasive, multidisciplinary, and therapies for treating chronic ailments. The company mainly offers treatment for health disease reversal, diabetes reversal, BP management, obesity management and knee pain relief. The company's business is divided into three segments i.e. Hospital Activity, Sale of Product and Common. It derives maximum revenue from Sale of Products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NSE:MADHAVBAUG has been successfully added to your 